Close Menu

NEW YORK (360Dx) – Aggredyne said today that the US Food and Drug Administration has granted clearance for its AggreGuide A-100 ADP Assay, a cartridge used to measure the effect of antiplatelet medications that target P2Y12, a platelet receptor.

The clearance allows the company to market the assay throughout the US and further expands the menu of tests that can be used with the firm's A-100 instrument, Aggredyne said. In 2013, the FDA cleared the A-100 instrument and a companion A-100 AA assay cartridge used to determine the effect of aspirin on platelet activity.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.